Is a complete GENB research report available?

No complete published report is available for Generate Biomedicines, Inc. (GENB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Generate Biomedicines, Inc. (GENB)

NASDAQ: GENB · USD

$15.2

+1.97 (+14.9%)· Recorded snapshot

Market cap	1.9B
Revenue (ttm)	26.5M
Net income (ttm)	-268.7M
EPS (ttm)	-$3.28
Shares out	128.4M
Volume	3,516,481

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 26.5M
Net income (ttm): -268.7M
EPS (ttm): -$3.28
Market cap: 1.9B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Metric	Value
Amount currency	USD
CIK code	0002100782
Company name	Generate Biomedicines, Inc.
Country	United States
Country code	US
CUSIP number	370920100
Earnings date	2026-11-10
Earnings time	amc
Employees	312
Enterprise value	$1.6B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2026-02-27
Is primary listing	Yes
Is SPAC	No
ISIN number	US3709201004
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$1.9B
Market cap category	Small-Cap
Next earnings date	2026-11-10
Options	No
Price	$15.19
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	GENB
Tags	pharmaceuticals
U.S. state	Massachusetts
Website	https://generatebiomedicines.com

Metric

Value

Amount currency

USD

CIK code

0002100782

Company name

Generate Biomedicines, Inc.

Country

United States

Country code

CUSIP number

370920100

Earnings date

2026-11-10

Earnings time

amc

Employees

312

Enterprise value

$1.6B

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2018

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2026-02-27

Is primary listing

Yes

Is SPAC

ISIN number

US3709201004

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$1.9B

Market cap category

Small-Cap

Next earnings date

2026-11-10

Options

Price

$15.19

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

GENB

Tags

pharmaceuticals

U.S. state

Massachusetts

Website

https://generatebiomedicines.com

Metric	Value
Earnings yield	-21.58%
EV/Sales	57.5x
FCF / EV yield	-16.05%
FCF yield	-12.74%
Forward EV/Sales	75.57x
Forward P/S	95.17x
P/B ratio	3.72x
P/S ratio	72.41x
Price / tangible book value	4.2x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-21.58%

EV/Sales

57.5x

FCF / EV yield

-16.05%

FCF yield

-12.74%

Forward EV/Sales

75.57x

Forward P/S

95.17x

P/B ratio

3.72x

P/S ratio

72.41x

Price / tangible book value

4.2x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Operating margin	-991.15%
Pretax margin	-946.77%
Profit per employee	$-861,135
Revenue per employee	$84,881
ROCE	-51.97%
SBC / revenue	94.32%
Tax / revenue	0.54%

Metric

Value

Operating margin

-991.15%

Pretax margin

-946.77%

Profit per employee

$-861,135

Revenue per employee

$84,881

ROCE

-51.97%

SBC / revenue

94.32%

Tax / revenue

0.54%

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth years	0
Revenue growth	55.89%
Revenue growth (Q)	-37.67%
Revenue growth (QoQ)	-12.6%
Revenue growth years	1

Metric

Value

EPS growth quarters

EPS growth years

Net income growth years

Revenue growth

55.89%

Revenue growth (Q)

-37.67%

Revenue growth (QoQ)

-12.6%

Revenue growth years

Metric	Value
Capital expenditures	$-7.3M
Depreciation and amortization	$12.9M
EBIT	$-262.5M
EBITDA	$-249.5M
EPS	$-3.28
FCF per share	$-1.90
Financing cash flow	$386.1M
Free cash flow	$-244.3M
Free cash flow minus SBC	$-269.3M
Gross profit	$-213.8M
Income taxes	$144,000
Investing cash flow	$-168.3M
Net borrowing	$-5.2M
Net cash flow	$-19.3M
Net income	$-268.7M
Operating cash flow minus SBC	$-262M
Operating income	$-262.5M
Revenue	$26.5M
Stock-based compensation	$25M

Metric

Value

Capital expenditures

$-7.3M

Depreciation and amortization

$12.9M

EBIT

$-262.5M

EBITDA

$-249.5M

EPS

$-3.28

FCF per share

$-1.90

Financing cash flow

$386.1M

Free cash flow

$-244.3M

Free cash flow minus SBC

$-269.3M

Gross profit

$-213.8M

Income taxes

$144,000

Investing cash flow

$-168.3M

Net borrowing

$-5.2M

Net cash flow

$-19.3M

Net income

$-268.7M

Operating cash flow minus SBC

$-262M

Operating income

$-262.5M

Revenue

$26.5M

Stock-based compensation

$25M

Metric	Value
Altman Z-Score	6.99
Book value per share	$3.56
Debt / equity	0.14
Interest coverage	-328.93
Long-term assets	$91.4M
Long-term liabilities	$49M
Net cash (debt)	$394.8M
Net cash / market cap	20.59%
Net debt / equity	-0.87
Piotroski F-Score	1
Property, plant and equipment	$82.4M
Shareholders' equity	$456M
Tangible book value	$456M
Tangible book value per share	$3.56
Total assets	$561.7M
Total cash	$457.4M
Total debt	$62.6M
Total liabilities	$105.6M

Metric

Value

Altman Z-Score

6.99

Book value per share

$3.56

Debt / equity

0.14

Interest coverage

-328.93

Long-term assets

$91.4M

Long-term liabilities

$49M

Net cash (debt)

$394.8M

Net cash / market cap

20.59%

Net debt / equity

-0.87

Piotroski F-Score

Property, plant and equipment

$82.4M

Shareholders' equity

$456M

Tangible book value

$456M

Tangible book value per share

$3.56

Total assets

$561.7M

Total cash

$457.4M

Total debt

$62.6M

Total liabilities

$105.6M

Metric	Value
Current assets	$470.3M
Current liabilities	$56.6M
Current ratio	8.3
Net working capital	$-30.2M
Quick ratio	8.08
Working capital	$413.6M

Metric

Value

Current assets

$470.3M

Current liabilities

$56.6M

Current ratio

8.3

Net working capital

$-30.2M

Quick ratio

8.08

Working capital

$413.6M

Metric	Value
Dividend yield	0%

Metric

Value

Dividend yield

Metric	Value
150-day SMA	$14.29
1D price change	14.95%
1M price change	-1.12%
1M total return	-1.12%
1W price change	16.12%
1W total return	16.12%
20-day SMA	$13.26
3M price change	9.5%
3M total return	9.5%
50-day SMA	$15.04
52-week high	$22.67
52-week high date	2026-08-25
52-week low	$11.00
52-week low date	2026-03-04
6M price change	20.32%
6M total return	20.32%
All-time high	$22.67
All-time high date	2026-08-25
All-time low	$11.00
All-time low date	2026-03-04
Average true range (ATR)	$0.96
Average volume	1M
Beta (1Y)	0.79
Change from 52-week high	-33.02%
Change from 52-week low	38.05%
Change from all-time high	-33.92%
Change from all-time low	36.18%
Change from open	9.32%
Day's gap	5.15%
Dollar volume	$53.4M
High price	$15.29
Low price	$13.89
Monthly RSI	0
Open price	$13.89
Position in 52-week range	92.5%
Premarket change	5.38%
Premarket close	$13.21
Premarket price	$13.92
Premarket volume	18.6K
Previous close	$13.21
Price vs 150-day SMA	4.87%
Price vs 20-day SMA	12.98%
Price vs 50-day SMA	-0.43%
Relative volume	3.5
Return from IPO open	-0.4%
Return from IPO price	-6.63%
RSI	57.87
Sharpe ratio	0.69
Sortino ratio	1.04
Volume	3.5M
Weekly RSI	52.55

Metric

Value

150-day SMA

$14.29

1D price change

14.95%

1M price change

-1.12%

1M total return

-1.12%

1W price change

16.12%

1W total return

16.12%

20-day SMA

$13.26

3M price change

9.5%

3M total return

9.5%

50-day SMA

$15.04

52-week high

$22.67

52-week high date

2026-08-25

52-week low

$11.00

52-week low date

2026-03-04

6M price change

20.32%

6M total return

20.32%

All-time high

$22.67

All-time high date

2026-08-25

All-time low

$11.00

All-time low date

2026-03-04

Average true range (ATR)

$0.96

Average volume

Beta (1Y)

0.79

Change from 52-week high

-33.02%

Change from 52-week low

38.05%

Change from all-time high

-33.92%

Change from all-time low

36.18%

Change from open

9.32%

Day's gap

5.15%

Dollar volume

$53.4M

High price

$15.29

Low price

$13.89

Monthly RSI

Open price

$13.89

Position in 52-week range

92.5%

Premarket change

5.38%

Premarket close

$13.21

Premarket price

$13.92

Premarket volume

18.6K

Previous close

$13.21

Price vs 150-day SMA

4.87%

Price vs 20-day SMA

12.98%

Price vs 50-day SMA

-0.43%

Relative volume

3.5

Return from IPO open

-0.4%

Return from IPO price

-6.63%

RSI

57.87

Sharpe ratio

0.69

Sortino ratio

1.04

Volume

3.5M

Weekly RSI

52.55

Metric	Value
Float	60.4M
Float percentage	47.1%
Shares change (QoQ)	97.68%
Shares held by insiders	4.07%
Shares held by institutions	30.65%
Shares outstanding	128.4M
Short % of float	14.77%
Short % of shares	6.96%
Short ratio	7.4 days

Metric

Value

Float

60.4M

Float percentage

47.1%

Shares change (QoQ)

97.68%

Shares held by insiders

4.07%

Shares held by institutions

30.65%

Shares outstanding

128.4M

Short % of float

14.77%

Short % of shares

6.96%

Short ratio

7.4 days

Generate Biomedicines, Inc. (GENB)

Price

Financial snapshot

Fair-value bridge

Latest news · GENB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GENB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on GENB

Frequently asked questions